What's Happening?
Alcami Corporation, a U.S.-based contract development and manufacturing organization (CDMO), has completed the acquisition of Tjoapack, a global contract packaging organization. This acquisition expands Alcami's capabilities across the U.S. and Europe,
enhancing its packaging scale and supply chain redundancy for pharmaceutical and biotech customers. The combined organization now employs over 1,400 personnel and operates more than 1 million square feet of facilities, supporting the production of over 80 commercial products worldwide. Alcami CEO Patrick Walsh will lead the combined entities, which aim to provide integrated global solutions for clients.
Why It's Important?
The acquisition is significant for the pharmaceutical and biotechnology industries as it strengthens Alcami's position in the market by expanding its operational footprint and capabilities. This move enhances Alcami's ability to offer end-to-end CDMO services, including drug product manufacturing, laboratory services, and pharma storage. The increased packaging scale and supply chain redundancy are crucial for meeting the growing demands of the pharmaceutical sector, ensuring uninterrupted service and improved market access. This strategic expansion aligns with Alcami's long-term growth strategy and commitment to providing comprehensive solutions to its clients.
